10 August 2012 - Inovio Pharmaceuticals Inc (NYSE MKT: INO), a company that produces vaccines to prevent and treat today's cancers and challenging infectious diseases, has today reported its financial results for the six months ended 30 June 2012.

The company posted total revenue at USD2.1m in the six months, compared with USD5.5m in the same period in 2011.

The firm reported total operating expenses at USD13.1m in the half year, against USD15m in the year-ago period.